{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:54:12Z","timestamp":1781582052569,"version":"3.54.5"},"reference-count":28,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMR"],"published-print":{"date-parts":[[2023,3,15]]},"abstract":"<jats:p>BACKGROUND: Fibromyalgia (FM) is a chronic disease that causes widespread pain, fatigue, and sleep disturbance. There is still no effective definitive treatment method; therefore, the search for treatment continues. OBJECTIVE: The purpose of this study is to investigate the effectiveness of ozone therapy (OT), which has been used in FM treatment in recent years, as an additional treatment. METHODS: The patients were divided into OT (n= 26) and placebo control (PC) (n= 28) groups. Both groups received OT in the form of major autohemotherapy (MaAHT) and minor autohemotherapy (MiAHT) for two sessions per week for a total of 10 sessions. The fibromyalgia impact questionnaire (FIQ), Pittsburgh sleep quality index (PSQI), and 12-item short-form health survey (SF-12) were used for evaluation pre- and post-intervention. RESULTS: In the between-group comparison, the OT group showed significant post-treatment improvements in FIQ subscales (feel good, fatigue) and PSQI total score and subscales (subjective sleep quality, sleep latency and sleep disturbances) compared to the PC group (p&lt; 0.05). Although there were improvements in the FIQ total score post-treatment in both groups, there was no significant difference between the groups (p&gt;0.05). CONCLUSION: OT, which is applied as an additional treatment with the autohemotherapy method, simultaneously improves the subscale scores (feel good and fatigue) of FM and sleep quality in the treatment period. However, changes in the post-treatment FIQ total score were not different in the ozone therapy group from the placebo control group.<\/jats:p>","DOI":"10.3233\/bmr-210368","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T11:47:08Z","timestamp":1670932028000},"page":"357-366","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of ozone therapy as an add-on treatment in fibromyalgia: A randomized double-blind placebo-controlled study"],"prefix":"10.1177","volume":"36","author":[{"given":"Hamza","family":"Sucuo\u011flu","sequence":"first","affiliation":[{"name":"Istanbul Gelisim University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalan","family":"Soyda\u015f","sequence":"additional","affiliation":[{"name":"Private Nisa Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/BMR-210368_ref1","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.3899\/jrheum.090367","article-title":"Fibromyalgia syndrome module at OMERACT 9: Domain construct","volume":"36","author":"Mease","year":"2009","journal-title":"J Rheumatol"},{"key":"10.3233\/BMR-210368_ref2","first-page":"6","article-title":"Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment","volume":"32","author":"Mease","year":"2005","journal-title":"J Rheumatol"},{"key":"10.3233\/BMR-210368_ref3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jbspin.2007.09.010","article-title":"Pathogenesis of fibromyalgia: A review","volume":"75","author":"Ablin","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.3233\/BMR-210368_ref4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jpsychores.2009.01.012","article-title":"Multidisciplinary treatment of fibromyalgia: Does cognitive behavior therapy increase the response to treatment","volume":"67","author":"Lera","year":"2009","journal-title":"J Psychosom Res"},{"key":"10.3233\/BMR-210368_ref5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ncprheum0221","article-title":"Therapy insight: Fibromyalgia-a different type of pain needing a different type of treatment","volume":"2","author":"Dadabhoy","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.3233\/BMR-210368_ref6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00296-005-0079-y","article-title":"Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: Etiologic and therapeutic concerns","volume":"26","author":"Ozgocmen","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.3233\/BMR-210368_ref7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.reuma.2010.12.007","article-title":"Oxidative stress in fibromyalgia: Pathophysiology and clinical implications","volume":"7","author":"Cordero","year":"2011","journal-title":"Reumatol Clin"},{"key":"10.3233\/BMR-210368_ref8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1089\/acm.2011.0739","article-title":"Ozone therapy as add-on treatment in fibromyalgia management by rectal insufflation: An open-label pilot study","volume":"19","author":"Hidalgo-Tallon","year":"2013","journal-title":"J Altern Complement Med"},{"key":"10.3233\/BMR-210368_ref9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00296-010-1470-x","article-title":"Pathophysiology and antioxidant status of patients with fibromyalgia","volume":"31","author":"Iqbal","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.3233\/BMR-210368_ref10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000236365","article-title":"Oxygen-ozone therapy in medicine: An update","volume":"28","author":"Bocci","year":"2009","journal-title":"Blood Purif"},{"key":"10.3233\/BMR-210368_ref11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.arcmed.2005.08.006","article-title":"Scientific and medical aspects of ozone therapy: The state of the art","volume":"37","author":"Bocci","year":"2006","journal-title":"Arch MedRes"},{"issue":"4","key":"10.3233\/BMR-210368_ref12","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.26355\/eurrev_201902_17141","article-title":"Ozone therapy in 65 patients with fibromyalgia: An effective therapy","volume":"23","author":"Tirelli","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10.3233\/BMR-210368_ref13","first-page":"244","article-title":"Autohemotherapy with ozone as a possible effective treatment for Fibromyalgia","volume":"44","author":"Moreno-Fern\u00e1ndez","year":"2019","journal-title":"Acta Reumatol Port"},{"key":"10.3233\/BMR-210368_ref14","doi-asserted-by":"publisher","first-page":"7969","DOI":"10.4081\/ozone.2018.7969","article-title":"Ozone therapy in 40 patients with fibromyalgia: An effective therapy","volume":"3","author":"Tirelli","year":"2018","journal-title":"Ozone Ther"},{"key":"10.3233\/BMR-210368_ref15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.3233\/BMR-210368_ref17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s002960000077","article-title":"The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire","volume":"20","author":"Sarmer","year":"2000","journal-title":"Rheumatol Int"},{"key":"10.3233\/BMR-210368_ref18","first-page":"107","article-title":"The validity and reliability of the Pittsburgh Sleep Quality Index","volume":"7","author":"Agarg\u00fcn","year":"1996","journal-title":"T\u00fcrk Psikiyatri Derg"},{"key":"10.3233\/BMR-210368_ref19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.21673\/anadoluklin.285068","article-title":"A comparison of the measuring instruments to assess quality of life in patients with fibromyalgia syndrome","volume":"22","author":"Ataoglu","year":"2017","journal-title":"Anatol Clin"},{"key":"10.3233\/BMR-210368_ref20","first-page":"154","article-title":"The Fibromyalgia Impact Questionnaire (FIQ): A review of its development, current version, operating characteristics and uses","volume":"23","author":"Bennet","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.3233\/BMR-210368_ref21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatr Res"},{"key":"10.3233\/BMR-210368_ref22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"10.3233\/BMR-210368_ref23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12955-018-0858-2","article-title":"Assessing the reliability of the short form 12 (SF-12) health survey in adults with mental health conditions: A report from the wellness incentive and navigation (WIN) study","volume":"16","author":"Huo","year":"2018","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"10.3233\/BMR-210368_ref24","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3899\/jrheum.081090","article-title":"Minimal clinically important difference in the fibromyalgia impact questionnaire","volume":"36","author":"Bennett","year":"2009","journal-title":"J Rheumatol"},{"key":"10.3233\/BMR-210368_ref25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/rheumatology\/40.7.743","article-title":"Cytokines play an aetiopathogenetic role in fibromyalgia: A hypothesis and pilot study","volume":"40","author":"Wallace","year":"2001","journal-title":"Rheumatology"},{"key":"10.3233\/BMR-210368_ref26","first-page":"149","article-title":"A novel therapeutic option for chronic fatigue syndrome and fibromyalgia","volume":"1","author":"Borrelli","year":"2002","journal-title":"Riv Ital Ossigeno Ozonoter"},{"key":"10.3233\/BMR-210368_ref27","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.3390\/ijms20164009","article-title":"The role of Nrf2 in the antioxidant cellular response to medical ozone exposure","author":"Gali\u00e8","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.3233\/BMR-210368_ref28","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy047"},{"issue":"4","key":"10.3233\/BMR-210368_ref29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10517-021-05095-6","article-title":"Low-dose ozone therapy improves sleep quality in patients with insomnia and coronary heart disease by elevating serum BDNF and GABA","volume":"170","author":"Li","year":"2021","journal-title":"Bull Exp Biol Med"}],"container-title":["Journal of Back and Musculoskeletal Rehabilitation"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/BMR-210368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:27:15Z","timestamp":1777382835000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/BMR-210368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":28,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/bmr-210368","relation":{},"ISSN":["1878-6324","1053-8127"],"issn-type":[{"value":"1878-6324","type":"electronic"},{"value":"1053-8127","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,15]]}}}